📰 Clinical Program News
Page 8 - Clinical Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Clinical Program. Real-time updates on events, politics, business and more.
December 29, 2023
Updated Interim Results for the Six Months Ended 30 June 2023 NEW YORK, December 29, 2023 - Tiziana Life Sciences, Ltd. , a biotechnology company developing breakthrough...
December 16, 2023
Takeda TSE4502NYSETAK today announced the European Medicines Agencys EMA Committee for Medicinal Products for Human Use CHMP has recommended the approval of HYQVIA Immune Globulin Infusion 10 Human with Recombinant Human Hyaluronidase in patients with chronic inflammatory demyelinating polyneuropathy CIDP as maintenance therapy after stabilization with intravenous immunoglobulin therapy IVIG.
December 16, 2023
If Approved, HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] Would Offer an up to Once-Monthly Facilitated Subcutaneous…
December 15, 2023
15.12.2023 - Takeda (TSE:4502/NYSE:TAK) today announced the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] ...
December 12, 2023
René van der Merwe, MBChB, appointed as Chief Medical Officer Tapan Maniar, Ph.D., joins as Chief Business Officer Company on track to initiate a Phase 2…
December 7, 2023
Lobe Sciences Ltd. ("Lobe" or the "Company"), a biopharmaceutical company focused on developing transformative medicines to treat rare diseases today provided an update from the Company's lead clinical program, L-130, a proprietary stabilized...
November 20, 2023
Approval is the culmination of 10 years of clinical research and development of the Medtronic renal denervation technology
November 20, 2023
After a mixed FDA panel review in August, the agency has approved Medtronics Symplicity Spyral renal denervation system for treatment of hypertension.
November 18, 2023
The Symplicity™ blood pressure procedure offers patients a new adjunct approach to lowering blood pressure Approval is the culmination of ten years of clinical research and development of the...
November 17, 2023
/PRNewswire/ - Apex Labs Ltd. (APEX or the Company), a pharmaceutical company transforming the standard of mental health care with psilocybin treatments...